PRF Technologies Ltd. (PRFX)
PRF Technologies Ltd. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
PRF Technologies Ltd. (PRFX) is a Drug Manufacturers - Specialty & Generic company based in IL with a market capitalization of $368K. Free cash flow was negative at -$4M. This page tracks PRFX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
IL · 2 employees · IPO Sep 1, 2020
Valuation
Valuation & price
$1.58 · as of May 17, 2026 · -86.7% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
0.04
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$368K
Market cap
—
Revenue growth (YoY)
-4864.7%
Gross margin
-$4M
Free cash flow (USD)
-$4.1M
Net debt
Net cash position
3471.7%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2017 → 2025
Free cash flow by year
2017 → 2025
Gross margin by year
2022 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: Jun 25, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Annual reportAnnual Report FiledJun 25, 2026Filing
- 6-K filingStandby Equity Purchase AgreementJun 18, 2026Filing
- 6-K filingProduct Development UpdateMay 28, 2026Filing
- 6-K filingPreclinical Study ResultsMay 26, 2026Filing
- 6-K filingStandby Equity Purchase AgreementMay 7, 2026Filing
- 6-K filingFDA Clearance AnnouncementApr 28, 2026Filing
Questions
Frequently asked questions
What is PRF Technologies Ltd.'s market cap?
PRF Technologies Ltd. (PRFX) has a market capitalization of $368K.
What is PRFX's P/E ratio?
A meaningful P/E ratio is not available for PRFX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is PRFX's price-to-book (P/B) ratio?
PRFX trades at 0.04 times book value per share.
When did PRF Technologies Ltd. last report earnings?
PRFX last reported earnings on June 25, 2026; the next date is not yet scheduled.
Are insiders buying PRFX stock?
SEC Form 4 filings show no open-market insider buys at PRF Technologies Ltd. in the last 90 days (0 sells).
Same arena
Related companies in Drug Manufacturers - Specialty & Generic
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.